Lombard Odier Asset Management Switzerland SA Makes New Investment in Humana Inc. $HUM

Lombard Odier Asset Management Switzerland SA acquired a new stake in Humana Inc. (NYSE:HUM) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 3,086 shares of the insurance provider’s stock, valued at approximately $535,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Montag A & Associates Inc. increased its holdings in shares of Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 94 shares during the period. CoreCap Advisors LLC boosted its stake in shares of Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after buying an additional 37 shares during the period. Fideuram Asset Management Ireland dac bought a new stake in shares of Humana in the fourth quarter valued at approximately $27,000. Reflection Asset Management acquired a new stake in Humana during the fourth quarter worth approximately $29,000. Finally, Global Assets Advisory LLC acquired a new stake in Humana during the first quarter worth approximately $38,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on HUM. Leerink Partners lifted their price objective on Humana from $185.00 to $255.00 and gave the company a “market perform” rating in a report on Thursday, April 30th. Jefferies Financial Group upgraded Humana from a “buy” rating to a “buy” rating in a research report on Wednesday, May 20th. Raymond James Financial set a $300.00 target price on Humana in a report on Tuesday, July 7th. UBS Group restated a “neutral” rating on shares of Humana in a research report on Monday, June 15th. Finally, Cantor Fitzgerald boosted their price target on Humana from $264.00 to $300.00 and gave the company a “neutral” rating in a research note on Tuesday, July 7th. Two analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, fifteen have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $327.17.

Humana Stock Performance

NYSE:HUM opened at $388.09 on Wednesday. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $428.88. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The stock’s 50-day simple moving average is $367.16 and its 200 day simple moving average is $266.44. The firm has a market capitalization of $46.59 billion, a PE ratio of 41.51, a price-to-earnings-growth ratio of 2.07 and a beta of 0.71.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping the consensus estimate of $9.97 by $0.34. The firm had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The business’s quarterly revenue was up 23.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $11.58 earnings per share. On average, analysts anticipate that Humana Inc. will post 9.46 EPS for the current fiscal year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.